Roundup™ Trial Developments
Roundup™ trial developments in the Edwin Hardeman case are being watched by scores of other potential plaintiffs. The trial remains in Phase 1 as of Friday, March 9. This phase has been set to establish medical causation. The judge told attorneys for Monsanto and the plaintiff that he would like to see Phase 1 conclude by the following week in order to proceed to phase 2 where damages would be determined. Attorneys for the plaintiff rested their case on Friday, making room for Monsanto to present its Phase 1 arguments. The Roundup™ trial developments are particularly crucial in this case, since in order for the trial to proceed to Phase 2, the jury must unanimously decide that Roundup™ was the cause of Hardeman’s cancer. However, before proceeding, the judge will allow debate over differences present in the trial instructions for Phase 1.